Clinical Trials Browser

Glioma, Central Nervous System Neoplasms

Clinical Stage I Gastric Cancer AJCC v8

Glioblastoma

Eyelid Squamous Cell Carcinoma

Brain Neoplasms, Craniopharyngioma

Oropharyngeal Neoplasms

Osteosarcoma

Glioblastoma

Squamous Cell Carcinoma of Head and Neck

Sinonasal Squamous Cell Carcinoma

Astrocytoma, Glioblastoma, Gliosarcoma

Lung Neoplasms

Glioblastoma

Anatomic Stage II Breast Cancer AJCC v8

Carcinoma, Non-Small-Cell Lung

Head and Neck Neoplasms, Pelvic Neoplasms

Leiomyosarcoma, Liposarcoma

Diabetes Insipidus, Germinoma

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms

Prostatic Neoplasms

Carcinoma, Squamous Cell, Skin Neoplasms

Colorectal Neoplasms

Clinical Trials

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer

Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma

Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer

A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection

MINT-2

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

STEMRI

A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma

Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)

Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

ERAS801-SARG

Oral Gallium Maltolate for Recurrent Glioblastoma

Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial

salVage

An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors

STRASS2

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

REGINA

SUGAR

INTerpath-007

SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases